Si-Liang Chen Selected Research

Si-Liang Chen Research Topics

6	Neoplasms (Cancer) 01/2022 - 02/2016
3	Carcinoma (Carcinomatosis) 05/2021 - 02/2016
3	Hepatic Encephalopathy 01/2020 - 10/2016
2	Neoplasm Metastasis (Metastasis) 05/2021 - 12/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2020
1	Multiple Myeloma 07/2022
1	Glioma (Gliomas) 01/2022
1	Infections 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Uveal melanoma 01/2022
1	Atherosclerosis 10/2021
1	Abdominal Aortic Aneurysm 10/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Leukemia 01/2021
1	Hemorrhage 01/2020
1	Pathologic Constriction (Stenosis) 01/2020
1	Margins of Excision 02/2016

2	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2021
2	Circular RNAIBA 05/2021 - 12/2018
1	selinexorIBA 07/2022
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2022
1	Tigecycline (Tygacil)FDA Link 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2022
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2022
1	LigandsIBA 01/2021
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2020
1	Cadherins (E-Cadherin)IBA 12/2018
1	Indicators and Reagents (Reagents)IBA 02/2016
1	Proteins (Proteins, Gene)FDA Link 02/2016

2	Therapeutics 01/2022 - 01/2021
2	Transjugular Intrahepatic Portasystemic Shunt 01/2020 - 10/2016
1	Vascular Surgical Procedures 10/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Punctures 01/2019
1	Cystectomy 02/2016